Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Alaunos rose 21.8% after adopting amended bylaws; Cheetah Net led gainers, while Xenon dropped 27.6% after pausing study enrollment.
Stocks · News reference
Filed: 2026-08-11 AccNo: 0001104659-26-093717 Size: 462 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Alaunos rose 21.8% after adopting amended bylaws; Cheetah Net led gainers, while Xenon dropped 27.6% after pausing study enrollment.
Canaccord Genuity analyst Austin Moeller initiates coverage on 908 Devices (NASDAQ:MASS) with a Buy rating and announces Price Target of $13.5.
Stifel analyst Daniel Arias maintains 908 Devices (NASDAQ:MASS) with a Buy and raises the price target from $10 to $12.
Roth Capital analyst Max Masucci maintains 908 Devices (NASDAQ:MASS) with a Buy and raises the price target from $11 to $13.